Jiangsu Bioperfectus Technologies Co Ltd
SSE:688399
Jiangsu Bioperfectus Technologies Co Ltd
SSE:688399
Price:
73.07 CNY
0.08%
Market Closed
Updated:
May 16, 2024
Balance Sheet
Balance Sheet Decomposition
Jiangsu Bioperfectus Technologies Co Ltd
Jiangsu Bioperfectus Technologies Co Ltd
| Current Assets | 2.9B |
| Cash & Short-Term Investments | 2.6B |
| Receivables | 82.1m |
| Other Current Assets | 138.7m |
| Non-Current Assets | 1.2B |
| Long-Term Investments | 414.6m |
| PP&E | 603.2m |
| Intangibles | 29.3m |
| Other Non-Current Assets | 131.3m |
| Current Liabilities | 454.8m |
| Accounts Payable | 42.7m |
| Accrued Liabilities | 25.7m |
| Short-Term Debt | 310m |
| Other Current Liabilities | 76.4m |
| Non-Current Liabilities | 133.3m |
| Long-Term Debt | 8.6m |
| Other Non-Current Liabilities | 124.7m |
Balance Sheet
Jiangsu Bioperfectus Technologies Co Ltd
Jiangsu Bioperfectus Technologies Co Ltd
Currency: CNY
| Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
12
|
22
|
212
|
249
|
1 139
|
667
|
1 262
|
1 769
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
647
|
1 228
|
1 761
|
|
| Cash Equivalents |
12
|
22
|
212
|
249
|
1 139
|
20
|
34
|
8
|
|
| Short-Term Investments |
196
|
196
|
0
|
581
|
298
|
1 243
|
1 545
|
695
|
|
| Total Receivables |
14
|
14
|
26
|
40
|
165
|
353
|
636
|
135
|
|
| Accounts Receivables |
8
|
10
|
18
|
36
|
158
|
343
|
564
|
109
|
|
| Other Receivables |
6
|
3
|
8
|
4
|
7
|
11
|
72
|
26
|
|
| Inventory |
15
|
18
|
14
|
19
|
163
|
250
|
236
|
94
|
|
| Other Current Assets |
6
|
1
|
2
|
2
|
15
|
25
|
30
|
17
|
|
| Total Current Assets |
244
|
251
|
254
|
891
|
1 780
|
2 539
|
3 709
|
2 710
|
|
| PP&E Net |
31
|
47
|
106
|
225
|
329
|
737
|
734
|
615
|
|
| PP&E Gross |
31
|
47
|
106
|
225
|
329
|
737
|
734
|
615
|
|
| Accumulated Depreciation |
10
|
19
|
31
|
46
|
61
|
98
|
313
|
409
|
|
| Intangible Assets |
3
|
2
|
26
|
26
|
27
|
27
|
27
|
30
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
96
|
123
|
254
|
416
|
|
| Other Long-Term Assets |
8
|
11
|
11
|
13
|
46
|
74
|
166
|
136
|
|
| Total Assets |
286
N/A
|
311
+9%
|
396
+27%
|
1 154
+192%
|
2 278
+97%
|
3 499
+54%
|
4 891
+40%
|
3 906
-20%
|
|
| Liabilities | |||||||||
| Accounts Payable |
5
|
8
|
9
|
45
|
109
|
353
|
433
|
75
|
|
| Accrued Liabilities |
7
|
15
|
17
|
21
|
197
|
154
|
173
|
90
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
82
|
162
|
89
|
158
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
7
|
8
|
8
|
|
| Other Current Liabilities |
19
|
26
|
29
|
29
|
134
|
179
|
229
|
33
|
|
| Total Current Liabilities |
31
|
48
|
55
|
94
|
522
|
856
|
933
|
364
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
7
|
11
|
9
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
1
|
4
|
16
|
0
|
|
| Other Liabilities |
3
|
2
|
16
|
39
|
90
|
97
|
153
|
129
|
|
| Total Liabilities |
34
N/A
|
50
+48%
|
72
+42%
|
134
+87%
|
613
+359%
|
963
+57%
|
1 113
+16%
|
501
-55%
|
|
| Equity | |||||||||
| Common Stock |
44
|
44
|
44
|
59
|
59
|
59
|
59
|
59
|
|
| Retained Earnings |
32
|
10
|
74
|
158
|
801
|
1 672
|
2 914
|
2 540
|
|
| Additional Paid In Capital |
176
|
206
|
206
|
805
|
805
|
806
|
806
|
807
|
|
| Total Equity |
252
N/A
|
260
+3%
|
324
+25%
|
1 021
+215%
|
1 665
+63%
|
2 536
+52%
|
3 778
+49%
|
3 405
-10%
|
|
| Total Liabilities & Equity |
286
N/A
|
311
+9%
|
396
+27%
|
1 154
+192%
|
2 278
+97%
|
3 499
+54%
|
4 891
+40%
|
3 906
-20%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
44
|
44
|
44
|
59
|
59
|
59
|
59
|
59
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
